tiprankstipranks
Trending News
More News >
United Therapeutics (UTHR)
NASDAQ:UTHR
US Market

United Therapeutics (UTHR) Income Statement

Compare
679 Followers

United Therapeutics Income Statement

Last quarter (Q3 2025), United Therapeutics's total revenue was $799.50M, an increase of 6.76% from the same quarter last year. In Q3, United Therapeutics's net income was $338.70M. See United Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.88B$ 2.33B$ 1.94B$ 1.69B$ 1.48B
Gross Profit
$ 2.57B$ 2.07B$ 1.79B$ 1.56B$ 1.38B
Operating Expenses
$ 1.19B$ 885.10M$ 809.90M$ 1.01B$ 781.60M
Depreciation and Amortization
$ 72.50M$ 53.20M$ 51.30M$ 49.90M$ 49.90M
EBITDA
$ 1.65B$ 1.39B$ 1.04B$ 736.80M$ 646.30M
Operating Income
$ 1.38B$ 1.18B$ 979.70M$ 555.90M$ 593.60M
Other Income/Expenses
$ 162.00M$ 89.40M$ -29.10M$ 38.00M$ 45.30M
Pretax Income
$ 1.54B$ 1.27B$ 950.60M$ 593.90M$ 638.90M
Net Income
$ 1.20B$ 984.80M$ 727.30M$ 475.80M$ 514.80M
Per Share Metrics
Basic EPS
$ 26.44$ 21.04$ 15.98$ 10.60$ 11.65
Diluted EPS
$ 24.64$ 19.81$ 15.00$ 10.06$ 11.54
Weighted Average Shares Outstanding
45.20M 46.80M 45.50M 44.90M 44.20M
Weighted Average Shares Outstanding (Diluted)
48.50M 49.70M 48.50M 47.30M 44.60M
Currency in USD

United Therapeutics Earnings and Revenue History